Thomas Scheier
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- Infection Control in Healthcare
- HIV/AIDS drug development and treatment
Papers in
-
- COVID-19 Clinical Research Studies 7
- Infection Control in Healthcare 7
- SARS-CoV-2 detection and testing 4
- SARS-CoV-2 and COVID-19 Research 4
- HIV/AIDS drug development and treatment 3
- Antimicrobial Resistance in Staphylococcus 3
- HIV/AIDS Research and Interventions 3
-
- COVID-19 epidemiological studies 4
- Co-authors
- Silvio D. Brugger (19 shared papers)Peter Werner Schreiber (12 shared papers)Daniel A. Hofmaenner (6 shared papers)Philipp K. Buehler (7 shared papers)Reto Andreas Schuepbach (5 shared papers)Pascal M. Frey (5 shared papers)Benjamin G. Hale (1 shared paper)Huldrych F. Günthard (8 shared papers)
- Journals
- Journal of Hospital Infection (4 papers)Emerging infectious diseases (3 papers)Antimicrobial Resistance and Infection Control (2 papers)Burns (2 papers)iScience (2 papers)
- Partner nations
- SwitzerlandCanadaGermany
In The Last Decade
Thomas Scheier
37 papers receiving 407 citations
Peers
Comparison fields: 5 of 51
- Infectious Diseases 179
- General Dentistry 3
- Modeling and Simulation 27
- Clinical Biochemistry 16
- Immunology 61
Countries citing papers authored by Thomas Scheier
This map shows the geographic impact of Thomas Scheier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Scheier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Scheier more than expected).
Fields of papers citing papers by Thomas Scheier
This network shows the impact of papers produced by Thomas Scheier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Scheier. The network helps show where Thomas Scheier may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Scheier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 60 | |
| 2 | 2021 | 42 | |
| 3 | 2022 | 28 | |
| 4 | 2021 | 26 | |
| 5 | 2022 | 24 | |
| 6 | 2024 | 22 | |
| 7 | 2021 | 18 | |
| 8 | 2022 | 16 | |
| 9 | 2022 | 14 | |
| 10 | 2016 | 12 | |
| 11 | 2020 | 12 | |
| 12 | 2024 | 12 | |
| 13 | 2022 | 11 | |
| 14 | 2023 | 11 | |
| 15 | 2021 | 10 | |
| 16 | 2023 | 10 | |
| 17 | 2022 | 9 | |
| 18 | 2021 | 8 | |
| 19 | 2022 | 8 | |
| 20 | 2023 | 6 |
About Thomas Scheier
Thomas Scheier is a scholar working on Infectious Diseases, Modeling and Simulation, Molecular Medicine, Critical Care and Intensive Care Medicine and Clinical Biochemistry, having authored 45 papers that have together received 413 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), Infection Control in Healthcare (7 papers), SARS-CoV-2 detection and testing (4 papers), COVID-19 epidemiological studies (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), HIV/AIDS drug development and treatment (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and HIV/AIDS Research and Interventions (3 papers). The work is most often cited by research in Infectious Diseases (179 citations), General Dentistry (3 citations), Modeling and Simulation (27 citations), Clinical Biochemistry (16 citations) and Immunology (61 citations). Thomas Scheier has collaborated with scholars based in Switzerland, Canada and Germany. Frequent co-authors include Silvio D. Brugger, Peter Werner Schreiber, Daniel A. Hofmaenner, Philipp K. Buehler, Reto Andreas Schuepbach, Pascal M. Frey, Benjamin G. Hale, Huldrych F. Günthard, Idoia Busnadiego and Irene Alma Abela. Their work appears in journals such as Journal of Hospital Infection, Emerging infectious diseases, Antimicrobial Resistance and Infection Control, Burns and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.